BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220616T120000
DTEND;TZID=America/New_York:20220616T130000
DTSTAMP:20260402T025141
CREATED:20220613T185224Z
LAST-MODIFIED:20220613T185224Z
UID:10001442-1655380800-1655384400@www.med.unc.edu
SUMMARY:Medicine Grand Rounds: Dr. Natalie Grover presents "An Internist's Guide to Chimeric Antigen Receptor T-Cell"
DESCRIPTION:Dr. Natalie Grover is an assistant professor in the division of hematology and clinical director of the cellular therapy program at the UNC School of Medicine. She received her MD from Case Western Reserve University. She completed her internal medicine residency at the University of Virginia and her hematology/oncology fellowship at the University of North Carolina at Chapel Hill. Her primary clinical and research interest is in novel therapies for the treatment of lymphoma\, particularly chimeric antigen receptor T-cell (CAR-T) therapy. She leads several CAR-T cell clinical trials in lymphoma and collaborates with translational researchers to bring these novel therapies to the clinic. She is interested in innovative approaches to improve the efficacy and safety of CAR-T cell therapy as well as investigations of why some patients progress after treatment. She is also involved in multi-center clinical trials and research collaborations with the goal of improving treatment options and quality of life for patients with lymphoma.
URL:https://www.med.unc.edu/medicine/event/medicine-grand-rounds-dr-natalie-grover-presents-an-internists-guide-to-chimeric-antigen-receptor-t-cell/
LOCATION:Old Clinic Auditorium
END:VEVENT
END:VCALENDAR